You are here

Article Text

Article menu
Download PDFPDF
Letters
Remission of Behçet's syndrome with TNFα blocking treatment
  1. M Rozenbaum,
  2. I Rosner,
  3. E Portnoy
  1. Department of Rheumatology, Bnai Zion Medical Centre, Technion Faculty of Medicine, Haifa, Israel
  1. Correspondence to:
    Dr Rosner;
    rosner{at}tx.technion.ac.il

https://doi.org/10.1136/ard.61.3.283-a

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Goossens et al reported on a patient in whom a remission of Behçet's syndrome was induced with tumour necrosis factor (TNF) blocking treatment.1 We would like to add our experience in a patient with Behçet's disease associated with rheumatoid arthritis (RA), treated with infliximab (Remicade).

    A 47 year old male patient, born in Morocco, living in Israel, was diagnosed 14 years earlier with severe, progressive polyarthritis of hands, feet, and knees. Radiography showed …

    View Full Text